Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine in Bipolar Depression (RGH-MD-56)
NCT01396447Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Jul 2011
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of cariprazine in bipolar disorder (BD) (4 arms), sponsored by Forest Laboratories. Primary endpoint: Montgomery-Åsberg Depression Rating Scale Total Score at 6 weeks. Started Jul 2011; status: completed.
02
Drugs
cariprazine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01396447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01396447.